Early recognition and diagnosis of multiple system atrophy: best practice and emerging concepts

References

• Gilman S, Wenning GK, Low PA, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology. 2008;71(9):670–676. .
   PubMed Web of Science ®Google Scholar
• Wenning GK, Colosimo C. Diagnostic criteria for multiple system atrophy and progressive supranuclear palsy. Rev Neurol (Paris). 2010;166(10):829–833.
   PubMed Web of Science ®Google Scholar
• Fanciulli A, Wenning GK, Longo DL. Multiple-system atrophy. N Engl J Med. 2015;372(3):249–263.
   PubMed Web of Science ®Google Scholar
• Watanabe H, Saito Y, Terao S, et al. Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients. Brain. 2002;125(Pt 5):1070–1083. .
   PubMed Web of Science ®Google Scholar
• Ben-Shlomo Y, Wenning GK, Tison F, et al. Survival of patients with pathologically proven multiple system atrophy: a meta-analysis. Neurology. 1997;48(2):384–393.
   PubMed Web of Science ®Google Scholar
• Klockgether T, Lüdtke R, Kramer B, et al. The natural history of degenerative ataxia: a retrospective study in 466 patients. Brain. 1998;121(Pt 4):589–600. .
   PubMed Web of Science ®Google Scholar
• Wenning GK, Geser F, Krismer F, et al. The natural history of multiple system atrophy: a prospective European cohort study. Lancet Neurol. 2013;12(3):264–274. .
   PubMed Web of Science ®Google Scholar
• Low PA, Reich SG, Jankovic J, et al. Natural history of multiple system atrophy in the USA: a prospective cohort study. Lancet Neurol. 2015;14(7):710–719. .
   PubMed Web of Science ®Google Scholar
• Giannini G, Calandra-Buonaura G, Mastrolilli F, et al. Early stridor onset and stridor treatment predict survival in 136 patients with MSA. Neurology. 2016;87(13):1375–1383. .
   PubMed Web of Science ®Google Scholar
• Coon EA, Sletten DM, Suarez MD, et al. Clinical features and autonomic testing predict survival in multiple system atrophy. Brain. 2015;138(12):3623–3631. .
   PubMed Web of Science ®Google Scholar
• Cao B, Zhang L, Zou Y, et al. Survival analysis and prognostic nomogram model for multiple system atrophy. Parkinsonism Relat Disord. 2018;54(68–73):68–73. .
   PubMed Web of Science ®Google Scholar
• Itoh K, Kasai T, Tsuji Y, et al. Definite familial multiple system atrophy with unknown genetics. Neuropathology. 2014;34(3):309–313. .
   PubMed Web of Science ®Google Scholar
• Stemberger S, Scholz SW, Singleton AB, et al. Genetic players in multiple system atrophy: unfolding the nature of the beast. Neurobiol Aging. 2011;32(10):e1925–1914.
   PubMed Web of Science ®Google Scholar
• Multiple-System Atrophy Research Collaboration. Mutations in COQ2 in familial and sporadic multiple-system atrophy. N Engl J Med. 2013 Jul 18;369(3):233-44. doi: https://doi.org/10.1056/NEJMoa1212115. Epub 2013 Jun 12. Erratum in: N Engl J Med. 2014 Jul 3;371(1):94. PMID: 23758206.
   Google Scholar
• Marsili L, Rizzo G, Colosimo C. Diagnostic Criteria for Parkinson’s Disease: from James Parkinson to the Concept of Prodromal Disease. Front Neurol. 2018;9(156). DOI:https://doi.org/10.3389/fneur.2018.00156
   Google Scholar
• Osaki Y, Ben-Shlomo Y, Lees AJ, et al. A validation exercise on the new consensus criteria for multiple system atrophy. Mov Disord. 2009;24(15):2272–2276.
   PubMed Web of Science ®Google Scholar
• Koga S, Aoki N, Uitti RJ, et al. When DLB, PD, and PSP masquerade as MSA: an autopsy study of 134 patients. Neurology. 2015;85(5):404–412. .
   PubMed Web of Science ®Google Scholar
• Stankovic I, Quinn N, Vignatelli L, et al. A critique of the second consensus criteria for multiple system atrophy. Mov Disord. 2019;34(7):975–984. .
   PubMed Web of Science ®Google Scholar
• Miki Y, Foti SC, Asi YT, et al. Improving diagnostic accuracy of multiple system atrophy: a clinicopathological study. Brain. 2019;142(9):2813–2827. .
   PubMed Web of Science ®Google Scholar
• Colosimo C. Nonmotor presentations of multiple system atrophy. Nat Rev Neurol. 2011;7(5):295–298.
   PubMed Web of Science ®Google Scholar
• Kaufmann H, Norcliffe-Kaufmann L, Palma JA, et al. Natural history of pure autonomic failure: a United States prospective cohort. Ann Neurol. 2017;81(2):287–297. .
   PubMed Web of Science ®Google Scholar
• Singer W, Berini SE, Sandroni P, et al. Pure autonomic failure: predictors of conversion to clinical CNS involvement. Neurology. 2017;88(12):1129–1136. .
   PubMed Web of Science ®Google Scholar
• Giannini G, Calandra-Buonaura G, Asioli GM, et al. The natural history of idiopathic autonomic failure: the IAF-BO cohort study. Neurology. 2018;91(13):e1245–e1254. .
   PubMed Web of Science ®Google Scholar
• Giannini G, Mastrangelo V, Provini F, et al. Progression and prognosis in multiple system atrophy presenting with REM behavior disorder. Neurology. 2020;94(17):e1828–e1834. .
   PubMed Web of Science ®Google Scholar
• Postuma RB, Iranzo A, Hu M, et al. Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study. Brain. 2019;142(3):744–759. .
   PubMed Web of Science ®Google Scholar
• Wenning GK, Colosimo C, Geser F, et al. Multiple system atrophy. Lancet Neurol. 2004;3(2):93–103.
   PubMed Web of Science ®Google Scholar
• Müller J, Wenning GK, Jellinger K, et al. Progression of Hoehn and Yahr stages in Parkinsonian disorders: a clinicopathologic study. Neurology. 2000;55(6):888–891.
   PubMed Web of Science ®Google Scholar
• Calandra-Buonaura G, Doria A, Lopane G, et al. Pharmacodynamics of a low subacute levodopa dose helps distinguish between multiple system atrophy with predominant Parkinsonism and Parkinson’s disease. J Neurol. 2016;263(2):250–256. .
   PubMed Web of Science ®Google Scholar
• Marsili L, Bologna M, Kojovic M, et al. Dystonia in atypical parkinsonian disorders. Parkinsonism Relat Disord. 2019;66(25–33):25–33.
   PubMed Web of Science ®Google Scholar
• Marsili L, Colosimo C. Dystonia in multiple system atrophy, progressive supra nuclear palsy, and corticobasal degeneration. In: Kanovsky B, editor. Dystonia and dystonic syndromes. Wien: Springer-Verlag; 2015. p. 88–89.
   Google Scholar
• Wenning GK, Ben-Shlomo Y, Hughes A, et al. What clinical features are most useful to distinguish definite multiple system atrophy from Parkinson’s disease? J Neurol Neurosurg Psychiatry. 2000;68(4):434–440.
   PubMed Web of Science ®Google Scholar
• Abele M, Bürk K, Schöls L, et al. The aetiology of sporadic adult-onset ataxia. Brain. 2002;125(5):961–968. .
   PubMed Web of Science ®Google Scholar
• Kanazawa M, Shimohata T, Toyoshima Y, et al. Cerebellar involvement in progressive supranuclear palsy: a clinicopathological study. Mov Disord. 2009;24(9):1312–1318. .
   PubMed Web of Science ®Google Scholar
• Lee JY, Lee WW, Kim JS, et al. Perverted head-shaking and positional downbeat nystagmus in patients with multiple system atrophy. Mov Disord. 2009;24(9):1290–1295.
   PubMed Web of Science ®Google Scholar
• Rusz J, Tykalová T, Salerno G, et al. Distinctive speech signature in cerebellar and parkinsonian subtypes of multiple system atrophy. J Neurol. 2019;266(6):1394–1404.
   PubMed Web of Science ®Google Scholar
• Tykalova T, Rusz J, Klempir J, et al. Distinct patterns of imprecise consonant articulation among Parkinson’s disease, progressive supranuclear palsy and multiple system atrophy. Brain Lang. 2017;165:1–9.
   PubMed Web of Science ®Google Scholar
• Calandra-Buonaura G, Alfonsi E, Vignatelli L, et al. Dysphagia in multiple system atrophy consensus statement on diagnosis, prognosis and treatment. Parkinsonism Relat Disord. 2021;86:124–132.
   PubMed Web of Science ®Google Scholar
• Wenning GK, Ben Shlomo Y, Magalhães M, et al. Clinical features and natural history of multiple system atrophy. An analysis of 100 cases. Brain. 1994;117(Pt 4):835–845.
   PubMed Web of Science ®Google Scholar
• Figueroa JJ, Singer W, Parsaik A, et al. Multiple system atrophy: prognostic indicators of survival. Mov Disord. 2014;29(9):1151–1157. .
   PubMed Web of Science ®Google Scholar
• Sakakibara R, Panicker J, Simeoni S, et al. Bladder dysfunction as the initial presentation of multiple system atrophy: a prospective cohort study. Clin Auton Res. 2019;29(6):627–631. .
   PubMed Web of Science ®Google Scholar
• McKay JH, Cheshire WP. First symptoms in multiple system atrophy. Clin Auton Res. 2018;28(2):215–221.
   PubMed Web of Science ®Google Scholar
• Fanciulli A, Stankovic I, Krismer F, et al.Multiple system atrophy. Int Rev Neurobiol. 2019;149(137–192)
   PubMed Web of Science ®Google Scholar
• Sakakibara R, Hattori T, Uchiyama T, et al. Videourodynamic and sphincter motor unit potential analyses in Parkinson’s disease and multiple system atrophy. J Neurol Neurosurg Psychiatry. 2001;71(5):600–606.
   PubMed Web of Science ®Google Scholar
• Sakakibara R, Shinotoh H, Uchiyama T, et al. Questionnaire-based assessment of pelvic organ dysfunction in Parkinson’s disease. Auton Neurosci. 2001;92(1–2):76–85. .
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Sakakibara R, Uchiyama T, et al. Questionnaire-based assessment of pelvic organ dysfunction in multiple system atrophy. Mov Disord. 2009;24(7):972–978. .
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Sakakibara R, Uchiyama T, et al. Pelvic organ dysfunction is more prevalent and severe in MSA-P compared to Parkinson’s disease. Neurourol Urodyn. 2011;30(1):102–107. .
   PubMed Web of Science ®Google Scholar
• Ito T, Sakakibara R, Yasuda K, et al. Incomplete emptying and urinary retention in multiple-system atrophy: when does it occur and how do we manage it? Mov Disord. 2006;21(6):816–823. .
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Asahina M, Yamanaka Y, et al. Postvoid residual predicts the diagnosis of multiple system atrophy in Parkinsonian syndrome. J Neurol Sci. 2017 Oct 15;381:230-234. doi:https://doi.org/10.1016/j.jns.2017.08.3262. Epub 2017 Sep 1. PMID: 28991688
   Google Scholar
• Yamamoto T, Tateno F, Sakakibara R, et al. Urinary Dysfunction in Progressive Supranuclear Palsy Compared with Other Parkinsonian Disorders. PLoS One. 2016;11(2):e0149278. .
   PubMed Web of Science ®Google Scholar
• Sakakibara R, Panicker J, Finazzi-Agro E, et al. A guideline for the management of bladder dysfunction in Parkinson’s disease and other gait disorders. Neurourol Urodyn. 2016;35(5):551–563.
   PubMed Web of Science ®Google Scholar
• Lin DJ, Hermann KL, Schmahmann JD. Multiple system atrophy of the cerebellar type: clinical state of the art. Mov Disord. 2014;29(3):294–304.
   PubMed Web of Science ®Google Scholar
• Wenning GK, Scherfler C, Granata R, et al. Time course of symptomatic orthostatic hypotension and urinary incontinence in patients with postmortem confirmed parkinsonian syndromes: a clinicopathological study. J Neurol Neurosurg Psychiatry. 1999;67(5):620–623. .
   PubMed Web of Science ®Google Scholar
• Höglinger GU, Kassubek J, Csoti I, et al. Differentiation of atypical Parkinson syndromes. J Neural Transm (Vienna). 2017;124(8):997–1004. .
   PubMed Web of Science ®Google Scholar
• Thaisetthawatkul P, Boeve BF, Benarroch EE, et al. Autonomic dysfunction in dementia with Lewy bodies. Neurology. 2004;62(10):1804–1809. .
   PubMed Web of Science ®Google Scholar
• Orimo S, Suzuki M, Inaba A, et al. 123I-MIBG myocardial scintigraphy for differentiating Parkinson’s disease from other neurodegenerative parkinsonism: a systematic review and meta-analysis. Parkinsonism Relat Disord. 2012;18(5):494–500.
   PubMed Web of Science ®Google Scholar
• Baschieri F, Calandra-Buonaura G, Doria A, et al. Cardiovascular autonomic testing performed with a new integrated instrumental approach is useful in differentiating MSA-P from PD at an early stage. Parkinsonism Relat Disord. 2015;21(5):477–482. .
   PubMed Web of Science ®Google Scholar
• Deguchi K, Sasaki I, Tsukaguchi M, et al. Abnormalities of rate-corrected QT intervals in Parkinson’s disease-a comparison with multiple system atrophy and progressive supranuclear palsy. J Neurol Sci. 2002;199(1–2):31–37. .
   PubMed Web of Science ®Google Scholar
• Deguchi K, Sasaki I, Ikeda K, et al. The validity of a hyperventilation test for an investigation of autonomic failure: assessment in patients with multiple system atrophy and Parkinson’s disease. Int J Clin Pract. 2006;60(12):1542–1547. .
   PubMed Web of Science ®Google Scholar
• Brisinda D, Sorbo AR, Di Giacopo R, et al. Cardiovascular autonomic nervous system evaluation in Parkinson disease and multiple system atrophy. J Neurol Sci. 2014;336(1–2):197–202.
   PubMed Web of Science ®Google Scholar
• Fanciulli A, Strano S, Ndayisaba JP, et al. Detecting nocturnal hypertension in Parkinson’s disease and multiple system atrophy: proposal of a decision-support algorithm. J Neurol. 2014;261(7):1291–1299. .
   PubMed Web of Science ®Google Scholar
• Fanciulli A, Jordan J, Biaggioni I, et al. Consensus statement on the definition of neurogenic supine hypertension in cardiovascular autonomic failure by the American Autonomic Society (AAS) and the European Federation of Autonomic Societies (EFAS): endorsed by the European Academy of Neurology (EAN) and the European Society of Hypertension (ESH). Clin Auton Res. 2018;28(4):355–362.
   PubMed Web of Science ®Google Scholar
• Lipp A, Sandroni P, Ahlskog JE, et al. Prospective differentiation of multiple system atrophy from Parkinson disease, with and without autonomic failure. Arch Neurol. 2009;66(6):742–750. .
   PubMedGoogle Scholar
• Iodice V, Lipp A, Ahlskog JE, et al. Autopsy confirmed multiple system atrophy cases: mayo experience and role of autonomic function tests. J Neurol Neurosurg Psychiatry. 2012;83(4):453–459. .
   PubMed Web of Science ®Google Scholar
• Coon EA, Fealey RD, Sletten DM, et al. Anhidrosis in multiple system atrophy involves pre- and postganglionic sudomotor dysfunction. Mov Disord. 2017;32(3):397–404. .
   PubMed Web of Science ®Google Scholar
• Cortelli P, Calandra-Buonaura G, Benarroch EE, et al. Stridor in multiple system atrophy: consensus statement on diagnosis, prognosis, and treatment. Neurology. 2019;93(14):630–639. .
   PubMed Web of Science ®Google Scholar
• Postuma RB, Berg D, Stern M, et al. MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord. 2015;30(12):1591–1601. .
   PubMed Web of Science ®Google Scholar
• Palma JA, Fernandez-Cordon C, Coon EA, et al. Prevalence of REM sleep behavior disorder in multiple system atrophy: a multicenter study and meta-analysis. Clin Auton Res. 2015;25(1):69–75. .
   PubMed Web of Science ®Google Scholar
• Munhoz RP, Teive HA. REM sleep behaviour disorder: how useful is it for the differential diagnosis of parkinsonism? Clin Neurol Neurosurg. 2014;127(71–74):71–74.
   PubMed Web of Science ®Google Scholar
• Nomura T, Inoue Y, Kagimura T, et al. Utility of the REM sleep behavior disorder screening questionnaire (RBDSQ) in Parkinson’s disease patients. Sleep Med. 2011;12(7):711–713.
   PubMed Web of Science ®Google Scholar
• Teive HA, Arruda WO, Moro A, et al. Differential diagnosis of sporadic adult-onset ataxia: the role of REM sleep behavior disorder. Parkinsonism Relat Disord. 2015;21(6):640–643.
   PubMed Web of Science ®Google Scholar
• Fereshtehnejad SM, Yao C, Pelletier A, et al. Evolution of prodromal Parkinson’s disease and dementia with Lewy bodies: a prospective study. Brain. 2019;142(7):2051–2067.
   PubMed Web of Science ®Google Scholar
• Bologna M, Suppa A, Di Stasio F, et al. Neurophysiological studies on atypical parkinsonian syndromes. Parkinsonism Relat Disord. 2017;42(12–21):12–21.
   PubMed Web of Science ®Google Scholar
• Kofler M, Müller J, Wenning GK, et al. The auditory startle reaction in parkinsonian disorders. Mov Disord. 2001;16(1):62–71. .
   PubMed Web of Science ®Google Scholar
• Kofler M, Müller J, Seppi K, et al. Exaggerated auditory startle responses in multiple system atrophy: a comparative study of parkinson and cerebellar subtypes. Clin Neurophysiol. 2003;114(3):541–547.
   PubMed Web of Science ®Google Scholar
• Bologna M, Marsili L, Khan N, et al. Blinking in patients with clinically probable multiple system atrophy. Mov Disord. 2014;29(3):415–420. .
   PubMed Web of Science ®Google Scholar
• Rossi S, Antal A, Bestmann S, et al. Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on training, ethical and regulatory issues: expert Guidelines. Clin Neurophysiol. 2021;132(1):269–306.
   PubMed Web of Science ®Google Scholar
• Abbruzzese G, Marchese R, Trompetto C. Sensory and motor evoked potentials in multiple system atrophy: a comparative study with Parkinson’s disease. Mov Disord. 1997;12(3):315–321.
   PubMed Web of Science ®Google Scholar
• Morita Y, Osaki Y, Doi Y. Transcranial magnetic stimulation for differential diagnostics in patients with parkinsonism. Acta Neurol Scand. 2008;118(3):159–163.
   PubMed Web of Science ®Google Scholar
• Cruz Martínez A, Arpa J, Alonso M, et al. Transcranial magnetic stimulation in multiple system and late onset cerebellar atrophies. Acta Neurol Scand. 1995;92(3):218–224.
   PubMed Web of Science ®Google Scholar
• Eusebio A, Azulay JP, Witjas T, et al. Assessment of cortico-spinal tract impairment in multiple system atrophy using transcranial magnetic stimulation. Clin Neurophysiol. 2007;118(4):815–823.
   PubMed Web of Science ®Google Scholar
• Kühn AA, Grosse P, Holtz K, et al. Patterns of abnormal motor cortex excitability in atypical parkinsonian syndromes. Clin Neurophysiol. 2004;115(8):1786–1795.
   PubMed Web of Science ®Google Scholar
• Marchese R, Trompetto C, Buccolieri A, et al. Abnormalities of motor cortical excitability are not correlated with clinical features in atypical parkinsonism. Mov Disord. 2000;15(6):1210–1214.
   PubMed Web of Science ®Google Scholar
• Suppa A, Marsili L, Di Stasio F, et al. Primary motor cortex long-term plasticity in multiple system atrophy. Mov Disord. 2014;29(1):97–104. .
   PubMed Web of Science ®Google Scholar
• Löscher WN, Stampfer-Kountchev M, Sawires M, et al. Abnormal responses to repetitive transcranial magnetic stimulation in multiple system atrophy. Mov Disord. 2007;22(2):174–178. .
   PubMed Web of Science ®Google Scholar
• Kawashima S, Ueki Y, Mima T, et al. Differences in dopaminergic modulation to motor cortical plasticity between Parkinson’s disease and multiple system atrophy. PLoS One. 2013;8(5):e62515.
   PubMed Web of Science ®Google Scholar
• Djurić-Jovičić M, Petrović I, Ječmenica-Lukić M, et al. Finger tapping analysis in patients with Parkinson’s disease and atypical parkinsonism. J Clin Neurosci. 2016;30(49–55):49–55. .
   PubMed Web of Science ®Google Scholar
• Schrag A, Good CD, Miszkiel K, et al. Differentiation of atypical parkinsonian syndromes with routine MRI. Neurology. 2000;54(3):697–702. .
   PubMed Web of Science ®Google Scholar
• Meer WG, Fernagut PO, Dehay B, et al. Multiple System Atrophy: recent Developments and Future Perspectives. Mov Disord. 2019;34(11):1629–1642. .
   PubMed Web of Science ®Google Scholar
• Huppertz HJ, Möller L, Südmeyer M, et al. Differentiation of neurodegenerative parkinsonian syndromes by volumetric magnetic resonance imaging analysis and support vector machine classification. Mov Disord. 2016;31(10):1506–1517. .
   PubMed Web of Science ®Google Scholar
• Scherfler C, Göbel G, Müller C, et al. Diagnostic potential of automated subcortical volume segmentation in atypical parkinsonism. Neurology. 2016;86(13):1242–1249. .
   PubMed Web of Science ®Google Scholar
• Barbagallo G, Sierra-Peña M, Nemmi F, et al. Multimodal MRI assessment of nigro-striatal pathway in multiple system atrophy and Parkinson disease. Mov Disord. 2016;31(3):325–334. .
   PubMed Web of Science ®Google Scholar
• Péran P, Barbagallo G, Nemmi F, et al. MRI supervised and unsupervised classification of Parkinson’s disease and multiple system atrophy. Mov Disord. 2018;33(4):600–608. .
   PubMed Web of Science ®Google Scholar
• Seki M, Seppi K, Mueller C, et al. Diagnostic Potential of Multimodal MRI Markers in Atypical Parkinsonian Disorders. J Parkinsons Dis. 2019;9(4):681–691. .
   PubMedGoogle Scholar
• Nocker M, Seppi K, Boesch S, et al. Topography of Dopamine Transporter Availability in the Cerebellar Variant of Multiple System Atrophy. Mov Disord Clin Pract. 2017;4(3):389–396. .
   PubMed Web of Science ®Google Scholar
• Ozawa T, Paviour D, Quinn NP, et al. The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations. Brain. 2004;127(Pt 12):2657–2671. .
   PubMed Web of Science ®Google Scholar
• Vergnet S, Hives F, Foubert-Samier A, et al. Dopamine transporter imaging for the diagnosis of multiple system atrophy cerebellar type. Parkinsonism Relat Disord. 2019;63(199–203):199–203. .
   PubMed Web of Science ®Google Scholar
• Kim JM, Lee JY, Kim HJ, et al. The wide clinical spectrum and nigrostriatal dopaminergic damage in spinocerebellar ataxia type 6. J Neurol Neurosurg Psychiatry. 2010;81(5):529–532.
   PubMed Web of Science ®Google Scholar
• Kim JY, Kim SY, Kim JM, et al. Spinocerebellar ataxia type 17 mutation as a causative and susceptibility gene in parkinsonism. Neurology. 2009;72(16):1385–1389. .
   PubMed Web of Science ®Google Scholar
• Cubo E, López MD, Ceberio JI, et al. Striatal dopamine function in a family with multiple SCA-3 phenotypes. J Neurol. 2011;258(2):308–310. .
   PubMed Web of Science ®Google Scholar
• Eckert T, Tang C, Ma Y, et al. Abnormal metabolic networks in atypical parkinsonism. Mov Disord. 2008;23(5):727–733. .
   PubMed Web of Science ®Google Scholar
• Tang CC, Poston KL, Eckert T, et al. Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis. Lancet Neurol. 2010;9(2):149–158. .
   PubMed Web of Science ®Google Scholar
• Hellwig S, Amtage F, Kreft A, et al. [18F]FDG-PET is superior to [123I]IBZM-SPECT for the differential diagnosis of parkinsonism. Neurology. 2012;79(13):1314–1322. .
   PubMed Web of Science ®Google Scholar
• Goldstein DS, Cheshire WP Jr. Roles of cardiac sympathetic neuroimaging in autonomic medicine. Clin Auton Res. 2018;28(4):397–410.
   PubMed Web of Science ®Google Scholar
• King AE, Mintz J, Royall DR. Meta-analysis of 123I-MIBG cardiac scintigraphy for the diagnosis of Lewy body-related disorders. Mov Disord. 2011;26(7):1218–1224.
   PubMed Web of Science ®Google Scholar
• Baschieri F, Calandra-Buonaura G, Cecere A, et al. Iodine-123-meta-iodobenzylguanidine Myocardial Scintigraphy in Isolated Autonomic Failure: potential Red Flag for Future Multiple System Atrophy. Front Neurol. 2017;8(225). DOI:https://doi.org/10.3389/fneur.2017.00225.
   Google Scholar
• Miyamoto T, Miyamoto M, Suzuki K, et al. 123I-MIBG cardiac scintigraphy provides clues to the underlying neurodegenerative disorder in idiopathic REM sleep behavior disorder. Sleep. 2008;31(5):717–723.
   PubMed Web of Science ®Google Scholar
• Satoh A, Serita T, Seto M, et al. Loss of 123I-MIBG uptake by the heart in Parkinson’s disease: assessment of cardiac sympathetic denervation and diagnostic value. J Nucl Med. 1999;40(3):371–375.
   PubMed Web of Science ®Google Scholar
• Kurata T, Kametaka S, Ohta Y, et al. PSP as distinguished from CBD, MSA-P and PD by clinical and imaging differences at an early stage. Intern Med. 2011;50(22):2775–2781. .
   PubMed Web of Science ®Google Scholar
• Fogel BL, Clark MC, Geschwind DH. The neurogenetics of atypical parkinsonian disorders. Semin Neurol. 2014;34(2):217–224.
   PubMed Web of Science ®Google Scholar
• Scholz SW, Houlden H, Schulte C, et al. SNCA variants are associated with increased risk for multiple system atrophy. Ann Neurol. 2009;65(5):610–614. .
   PubMed Web of Science ®Google Scholar
• Ahmed Z, Asi YT, Sailer A, et al. The neuropathology, pathophysiology and genetics of multiple system atrophy. Neuropathol Appl Neurobiol. 2012;38(1):4–24. .
   PubMed Web of Science ®Google Scholar
• Sasaki H, Emi M, Iijima H, et al. Copy number loss of (src homology 2 domain containing)-transforming protein 2 (SHC2) gene: discordant loss in monozygotic twins and frequent loss in patients with multiple system atrophy. Mol Brain. 2011;4(24):24. .
   Google Scholar
• Ferguson MC, Garland EM, Hedges L, et al. SHC2 gene copy number in multiple system atrophy (MSA). Clin Auton Res. 2014;24(1):25–30. .
   PubMed Web of Science ®Google Scholar
• Lee K, Nguyen KD, Sun C, et al. LRRK2 p.Ile1371Val Mutation in a Case with Neuropathologically Confirmed Multi-System Atrophy. J Parkinsons Dis. 2018;8(1):93–100. .
   PubMedGoogle Scholar
• Riboldi GM, Palma JA, Cortes E, et al. Early-onset pathologically proven multiple system atrophy with LRRK2 G2019S mutation. Mov Disord. 2019;34(7):1080–1082. .
   PubMed Web of Science ®Google Scholar
• Sklerov M, Kang UJ, Liong C, et al. Frequency of GBA variants in autopsy-proven multiple system atrophy. Mov Disord Clin Pract. 2017;4(4):574–581. .
   PubMed Web of Science ®Google Scholar
• Kiely AP, Asi YT, Kara E, et al. α-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson’s disease and multiple system atrophy? Acta Neuropathol. 2013;125(5):753–769. .
   PubMed Web of Science ®Google Scholar
• Pasanen P, Myllykangas L, Siitonen M, et al. Novel α-synuclein mutation A53E associated with atypical multiple system atrophy and Parkinson’s disease-type pathology. Neurobiol Aging. 2014;35(9):e2181–2185. .
   Web of Science ®Google Scholar
• Laurens B, Constantinescu R, Freeman R, et al. Fluid biomarkers in multiple system atrophy: a review of the MSA Biomarker Initiative. Neurobiol Dis. 2015;80(29–41). DOI:https://doi.org/10.1016/j.nbd.2015.05.004.
   Google Scholar
• Jellinger KA. Potential clinical utility of multiple system atrophy biomarkers. Expert Rev Neurother. 2017;17(12):1189–1208.
   PubMed Web of Science ®Google Scholar
• Doppler K, Weis J, Karl K, et al. Distinctive distribution of phospho-alpha-synuclein in dermal nerves in multiple system atrophy. Mov Disord. 2015;30(12):1688–1692. .
   PubMed Web of Science ®Google Scholar
• Donadio V. Skin nerve α-synuclein deposits in Parkinson’s disease and other synucleinopathies: a review. Clin Auton Res. 2019;29(6):577–585.
   PubMed Web of Science ®Google Scholar
• Donadio V, Incensi A, Rizzo G, et al. Skin Biopsy May Help to Distinguish Multiple System Atrophy-Parkinsonism from Parkinson’s Disease With Orthostatic Hypotension. Mov Disord. 2020;35(9):1649–1657. .
   PubMed Web of Science ®Google Scholar
• Donadio V, Incensi A, El-Agnaf O, et al. Skin α-synuclein deposits differ in clinical variants of synucleinopathy: an in vivo study. Sci Rep. 2018;8(1):14246. .
   PubMed Web of Science ®Google Scholar
• Wang Z, Becker K, Donadio V, et al. Skin α-Synuclein Aggregation Seeding Activity as a Novel Biomarker for Parkinson Disease. JAMA Neurol. 2020;78(1):1–11.
   Web of Science ®Google Scholar
• Rossi M, Candelise N, Baiardi S, et al. Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies. Acta Neuropathol. 2020;140(1):49–62. .
   PubMed Web of Science ®Google Scholar
• Youssef P, Kim WS, Halliday GM, et al. Comparison of Different Platform Immunoassays for the Measurement of Plasma Alpha-Synuclein in Parkinson’s Disease Patients. J Parkinsons Dis. 2021;1–12. DOI:https://doi.org/10.3233/JPD-212694
   Google Scholar
• Abdo WF, De Jong D, Hendriks JC, et al. Cerebrospinal fluid analysis differentiates multiple system atrophy from Parkinson’s disease. Mov Disord. 2004;19(5):571–579. .
   PubMed Web of Science ®Google Scholar
• Goldstein DS, Holmes C, Sharabi Y. Cerebrospinal fluid biomarkers of central catecholamine deficiency in Parkinson’s disease and other synucleinopathies. Brain. 2012;135(Pt 6):1900–1913.
   PubMed Web of Science ®Google Scholar
• Goldstein DS, Holmes C, Patronas N, et al. Cerebrospinal fluid levels of catechols in patients with neurogenic orthostatic hypotension. Clin Sci (Lond). 2003;104(6):649–654.
   PubMed Web of Science ®Google Scholar
• Bhidayasiri R, Sringean J, Reich SG, et al. Red flags phenotyping: a systematic review on clinical features in atypical parkinsonian disorders. Parkinsonism Relat Disord. 2019;59(82–92):82–92.
   Google Scholar
• Orimo S, Kanazawa T, Nakamura A, et al. Degeneration of cardiac sympathetic nerve can occur in multiple system atrophy. Acta Neuropathol. 2007;113(1):81–86. .
   PubMed Web of Science ®Google Scholar
• Nagayama H, Ueda M, Yamazaki M, et al. Abnormal cardiac [(123)I]-meta-iodobenzylguanidine uptake in multiple system atrophy. Mov Disord. 2010;25(11):1744–1747.
   PubMed Web of Science ®Google Scholar
• Schirinzi T, Canevelli M, Suppa A, et al. The continuum between neurodegeneration, brain plasticity, and movement: a critical appraisal. Rev Neurosci. 2020;31(7):723–742.
   PubMed Web of Science ®Google Scholar
• Marsili L, Espay AJ, Merola A. Future of Neurologic Examination in Clinical Practice. JAMA Neurol. 2018;75(3):383.
   PubMed Web of Science ®Google Scholar
• O’Sullivan SS, Massey LA, Williams DR, et al. Clinical outcomes of progressive supranuclear palsy and multiple system atrophy. Brain. 2008;131(Pt 5):1362–1372. .
   PubMed Web of Science ®Google Scholar
• Marsili L, Vizcarra JA, Sturchio A, et al. When does postural instability appear in monogenic parkinsonisms? An individual-patient meta-analysis. J Neurol. 2020. DOI:https://doi.org/10.1007/s00415-020-09892-3.
   Google Scholar
• Espay AJ, Vizcarra JA, Marsili L, et al. Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases. Neurology. 2019;92(7):329–337. .
   PubMed Web of Science ®Google Scholar
• Laurens B, Vergnet S, Lopez MC, et al. Multiple System Atrophy - State of the Art. Curr Neurol Neurosci Rep. 2017;17(5):41. .
   PubMed Web of Science ®Google Scholar
• Greene P. Progressive Supranuclear Palsy, Corticobasal Degeneration, and Multiple System Atrophy. Continuum (Minneap Minn). 2019;25(4):919–935.
   PubMedGoogle Scholar
• Kagohashi M, Okuma Y, Fujishima K, et al. Blepharospasm associated with multiple system atrophy: a case report and review of the literature. Parkinsonism Relat Disord. 2004;10(3):169–171.
   PubMed Web of Science ®Google Scholar
• Mascia MM, Valls-Solé J, Martí MJ, et al. Sensorimotor integration in patients with parkinsonian type multisystem atrophy. J Neurol. 2005;252(4):473–481.
   PubMed Web of Science ®Google Scholar
• Serrao M, Di Fabio R, Bartolo M, et al. The contribution of trigemino-cervical reflexes in distinguishing progressive supranuclear palsy from multiple system atrophy. Clin Neurophysiol. 2011;122(9):1812–1815. .
   PubMed Web of Science ®Google Scholar
• von Lewinski F, Schwan M, Paulus W, et al. Impairment of brainstem implicit learning paradigms differentiates multiple system atrophy (MSA) from idiopathic Parkinson syndrome. BMJ Open. 2013;3(9):e003098.
   PubMed Web of Science ®Google Scholar
• Quinn N. Multiple system atrophy--the nature of the beast. J Neurol Neurosurg Psychiatry. 1989 Jun;Suppl(Suppl):78-89. doi: https://doi.org/10.1136/jnnp.52.suppl.78. PMID: 2666581; PMCID: PMC1033311.
   Google Scholar
• Gilman S, Low PA, Quinn N, et al. Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci. 1999;163(1):94–98. .
   PubMed Web of Science ®Google Scholar